DE69104022D1 - Antibiotisches zyklisches Hexapeptid. - Google Patents

Antibiotisches zyklisches Hexapeptid.

Info

Publication number
DE69104022D1
DE69104022D1 DE69104022T DE69104022T DE69104022D1 DE 69104022 D1 DE69104022 D1 DE 69104022D1 DE 69104022 T DE69104022 T DE 69104022T DE 69104022 T DE69104022 T DE 69104022T DE 69104022 D1 DE69104022 D1 DE 69104022D1
Authority
DE
Germany
Prior art keywords
cyclic hexapeptide
antibiotic cyclic
antibiotic
hexapeptide
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69104022T
Other languages
English (en)
Other versions
DE69104022T2 (de
Inventor
Robert E Schwartz
Thomas C Hallada
Prakash S Masurekar
Otto D Hensens
Jerrold M Liesch
David F Sesin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69104022D1 publication Critical patent/DE69104022D1/de
Application granted granted Critical
Publication of DE69104022T2 publication Critical patent/DE69104022T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69104022T 1990-12-19 1991-12-11 Antibiotisches zyklisches Hexapeptid. Expired - Fee Related DE69104022T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/630,457 US5306708A (en) 1990-12-19 1990-12-19 Antibiotic agent

Publications (2)

Publication Number Publication Date
DE69104022D1 true DE69104022D1 (de) 1994-10-20
DE69104022T2 DE69104022T2 (de) 1995-04-13

Family

ID=24527241

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69104022T Expired - Fee Related DE69104022T2 (de) 1990-12-19 1991-12-11 Antibiotisches zyklisches Hexapeptid.

Country Status (7)

Country Link
US (1) US5306708A (de)
EP (1) EP0494515B1 (de)
JP (1) JP3067869B2 (de)
AT (1) ATE111487T1 (de)
CA (1) CA2057711C (de)
DE (1) DE69104022T2 (de)
IE (1) IE914418A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE910892A1 (en) * 1990-03-19 1991-09-25 Merck & Co Inc Lipopeptide compounds
TW199162B (de) * 1991-05-09 1993-02-01 Fujisawa Pharmaceutical Co
ATE223226T1 (de) * 1994-09-16 2002-09-15 Merck & Co Inc Azazyklohexapeptid-verbindungen
AU8857401A (en) * 2000-08-31 2002-03-13 Hauser Inc Efficient method for producing compositions enriched in anthocyanins
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
CN102618604B (zh) * 2011-01-31 2014-09-03 上海天伟生物制药有限公司 一种环脂肽化合物的制备方法
WO2019207413A1 (en) 2018-04-25 2019-10-31 Universidad De La República (Udelar) Cyclic hexapeptides compounds with anti-malarial activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5021341A (en) * 1990-03-12 1991-06-04 Merck & Co., Inc. Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol

Also Published As

Publication number Publication date
US5306708A (en) 1994-04-26
ATE111487T1 (de) 1994-09-15
CA2057711C (en) 2002-01-22
CA2057711A1 (en) 1992-06-20
EP0494515A1 (de) 1992-07-15
JP3067869B2 (ja) 2000-07-24
DE69104022T2 (de) 1995-04-13
JPH0692992A (ja) 1994-04-05
EP0494515B1 (de) 1994-09-14
IE914418A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
FI905575A0 (fi) Ny polypeptidfoerening och foerfarande foer dess framstaellning.
KR930703355A (ko) 항생물질 ge2270 인자의 아미드
DK0934950T3 (da) Tetrapeptidderivat
NO893166D0 (no) Makrocykliske forbindelser.
FI911286A0 (fi) Kemiska foereningar.
IL94862A0 (en) Antibiotic compound,its production and pharmaceutical compositions containing it
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
DE69424147D1 (de) Vorrichtung für die vaginale Verabreichung von Tamoxifen und dessen Analogen
HU913462D0 (en) Process for the production of heteroaroyl derivatives of moncyclic betha-lactame antibiotics and of medical preparations containing them
DE69104022D1 (de) Antibiotisches zyklisches Hexapeptid.
DE69029040D1 (de) Megakaryocytopoietischer faktor
FI930092A (fi) Indanopyrrolidinkarbamater
ES2054171T3 (es) Agente radioactivo de diagnostico.
PT713702E (pt) Agente ansiolitico
FI892229A0 (fi) Antibiotikafoereningar.
SE9201188L (sv) Ny användning
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
BG95629A (en) Derivatives of 10, 11, 12, 13 - tetrahytdrodesmicozine, method for preparing them, and their use as pharmaceutical preparations
SU1793687A1 (ru) 5,7-(1-Гидрокси-1-трифторметил-2,2,2-трифторэтил)-замещенные 8-оксихинолины, проявляющие противомикробную активность относительно грамположительных бактерий и споровых культур
SU1795646A1 (ru) Комплекс 2-ацетиламино-5-нитротиазола с поливинилпирролидоном, обладающий антимикробной активностью по отношению к неспорообразующей анаэробной инфекции

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee